What is JBP PLAMON injection used for?

JBP PLAMON injection is a human placenta extract injection. Its approved indication in the Korean MFDS product record is improvement of menopausal disorder symptoms.

What is JBP PLAMON's active ingredient?

The active ingredient is Human Placenta Extract, 50 mg of water-soluble substances per mL (100 mg per 2mL ampoule). Each box contains 10 ampoules of 2mL each.

How is JBP PLAMON administered?

It is administered by subcutaneous injection only. The labeled course is one 2mL ampoule three times a week for two weeks (six injections total), changing the injection site each time.

Who should administer JBP PLAMON and what are the precautions?

Professional administration is recommended. It must not be used in patients with hypersensitivity to this or other drugs, suspected organic disease, severe complications of the heart, liver, kidney, or other organs, or psychogenic disorders, or in newborns and premature infants (it contains benzyl alcohol). Because it is made from human placenta, the risk of infection transmission cannot be completely excluded. Sterile technique must be maintained and glass ampoules handled carefully to prevent glass fragment contamination.

Kstation

JBP PLAMON Inj (2mL × 10 Amps)

$61.00

Specification 2cc 10 Amp / Box

Quantity

Formulation

Key ingredients

01 Human Placenta Extract50 mg/mL (water-soluble substances)Improvement of menopausal disorder symptoms (MFDS indication)

SUBCUTANEOUS INJECTION • PLACENTA EXTRACT

JBP PLAMON Injection

2mL x 10 Ampoules

Human placenta extract injection. MFDS-approved indication: improvement of menopausal disorder symptoms

Why KSTATION

TRUST

✅

100% Authentic

Genuine Korean supply

🛃

97% Clearance

Proven customs success rate

❄️

Cold-Chain

Temperature-controlled shipping

[MAIN PRODUCT PHOTOGRAPHY - JBP PLAMON PACKAGING AND AMPOULES]

Ingredients & Composition

ING-001

Human Placenta Extract: Human placenta extract, 50 mg of water-soluble substances per mL (100 mg per 2mL ampoule), as listed in the Korean MFDS product record. Contains benzyl alcohol.
High Potency Medical Grade

Approved Indication

In the Korean MFDS product record (item code 200708605), the approved indication is improvement of menopausal disorder symptoms.

MFDS

Key Facts

Approved indication: improvement of menopausal disorder symptoms
Human placenta extract, 50 mg water-soluble substances per mL
For subcutaneous injection only
Labeled course: 2mL, three times a week for two weeks

[BEFORE/AFTER RESULTS AND CLINICAL EFFECTS DOCUMENTATION]

Effects & Benefits

EFF-002

Menopausal Support

Improvement of menopausal disorder symptoms, the indication listed in the Korean MFDS product record.

Approved Indication

Usage & Application Method

USE-003

Preparation

Ensure sterile conditions and prepare injection site. Check ampoule integrity and allow to reach room temperature if refrigerated.

Administration

Administer by subcutaneous injection only. Avoid nerve pathways when choosing the injection site.

Treatment Cycle

Typically, one ampoule (2ml) is administered three times a week for two weeks (total of six injections).

Site Rotation

Change the injection site each time (for example, alternate left and right) and avoid repeated injection into the same site.

[STEP-BY-STEP INJECTION TECHNIQUE AND SITE ROTATION GUIDE]

Target Recommendations

TRG-004

Target Group	Symptoms/Condition	Benefits
Adults with Menopausal Symptoms	Menopausal disorder symptoms	Approved indication: improvement of menopausal disorder symptoms

Important Safety Information

Professional administration recommended for optimal safety and effectiveness. Important precautions to ensure safe usage:

Do not use in patients with hypersensitivity to this or other drugs
Do not use in patients with suspected organic disease
Do not use in patients with severe complications of the heart, liver, kidney, or other organs
Do not use in patients with psychogenic disorders
Do not use in newborns or premature infants (contains benzyl alcohol)
Use with caution in patients with an allergic constitution
Made from human placenta: donor screening and inactivation steps are applied, but the risk of infection transmission cannot be completely excluded
Handle glass ampoules carefully to prevent glass fragment contamination
Maintain sterile technique throughout administration
Monitor for any adverse reactions during treatment

Storage & Handling

STG-005

Storage Requirements

Temperature: Store at room temperature 1-30°C
Light Protection: Keep in light-resistant, sealed container
Freezing: Do not freeze
Container: Maintain original sealed packaging

Handling Precautions

Open glass ampoules carefully to minimize risk of contamination
Use immediately after opening
Ensure sterile technique during handling
Dispose of used ampoules according to medical waste guidelines

[PROPER STORAGE CONDITIONS AND HANDLING SAFETY GUIDELINES]

Product Specifications

SPC-006

Product Name: JBP PLAMON injection
Volume per Ampoule: 2mL
Package Contents: 10 Ampoules per box
Active Ingredient: Human Placenta Extract (50 mg/mL as water-soluble substances)
Administration Route: Subcutaneous injection only
Recommended Course: 6 injections over 2 weeks (3x per week)

[PROFESSIONAL CERTIFICATION AND QUALITY ASSURANCE DOCUMENTATION]

Frequently Asked Questions

FAQ-007

What is JBP PLAMON injection used for?: JBP PLAMON injection is a human placenta extract injection. Its approved indication in the Korean MFDS product record is improvement of menopausal disorder symptoms.
What is JBP PLAMON's active ingredient?: The active ingredient is Human Placenta Extract, 50 mg of water-soluble substances per mL (100 mg per 2mL ampoule). Each box contains 10 ampoules of 2mL each.
How is JBP PLAMON administered?: It is administered by subcutaneous injection only. The labeled course is one 2mL ampoule three times a week for two weeks (six injections total), changing the injection site each time.
Who should administer JBP PLAMON and what are the precautions?: Professional administration is recommended. It must not be used in patients with hypersensitivity to this or other drugs, suspected organic disease, severe complications of the heart, liver, kidney, or other organs, or psychogenic disorders, or in newborns and premature infants (it contains benzyl alcohol). Because it is made from human placenta, the risk of infection transmission cannot be completely excluded. Sterile technique must be maintained and glass ampoules handled carefully to prevent glass fragment contamination.